Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sanofi Insider Profile

18 Followers

Sanofi, Ten Percent Owner at Latigo Biotherapeutics, Inc., holds 672.79K shares in Latigo Biotherapeutics, Inc. (Ticker: LTGO), holds 1.08M shares in Attovia Therapeutics, Inc. (Ticker: ATTO), holds 75.67M shares in Translate Bio (Ticker: ~TBIO).

Sanofi's Trading History

LTGOLatigo Biotherapeutics, Inc.		Aug 12, 2026Ten Percent OwnerUninformative Buy―$8.48M
ATTOAttovia Therapeutics, Inc.		Aug 07, 2026Ten Percent OwnerUninformative Buy―$16.54M
~TBIOTranslate Bio		Sep 14, 2021―Uninformative Buy1.96B$2.87B
ICVXIcosavax		Aug 02, 2021―Informative Buy1.00M$48.31M
INZYInozyme Pharma		Jul 29, 2020―Uninformative Buy―$2.08M
REGNRegeneron		Jun 11, 2020Ten Percent OwnerInformative Sell71.84M$253.01M
FULCFulcrum Therapeutics		Jul 23, 2019Ten Percent OwnerUninformative Buy―$2.06M
MYOKMyoKardia		Feb 15, 2019―Informative Sell157.00M$0.00
ALNYAlnylam Pharma		Jun 01, 2017Ten Percent OwnerInformative Buy21.38M$1.60B
SCYXSCYNEXIS		May 09, 2014Ten Percent OwnerInformative Buy―$5.87M
RGLSRegulus		Feb 05, 2014―Informative Buy10.00M$41.24M
CBIOCrescent Biopharma		Nov 06, 2013Ten Percent OwnerInformative Buy―$16.16M
HGENQHumanigen		Feb 07, 2013―Informative Buy700.00K$6.37K
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Sanofi insider profile FAQ

What is the percentage of profitable transactions made by Sanofi?
The percentage of profitable transactions made by Sanofi is 60%.
What is the average return per transaction made by Sanofi?
The average return per transaction made by Sanofi is 15.20%.
What stocks does Sanofi hold?
Sanofi holds: LTGO, REGN, MYOK, ~TBIO, FULC, INZY, ICVX, ATTO, ALNY, RGLS, SCYX, CBIO, HGENQ stocks.
What was Sanofi's most profitable transaction?
Sanofi’s most profitable transaction was an Informative Buy of MYOK stock on October 5, 2016. The return on the trade was 145.60%.
What is Sanofi's role in Latigo Biotherapeutics, Inc.?
Sanofi's role in Latigo Biotherapeutics, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.